Artificial Intelligence in Public Health: Bridging Today’s Trends with Tomorrow’s Possibilities.

Publication date: May 23, 2025

Driven by the unprecedented challenges of the COVID-19 pandemic, the healthcare sector has witnessed remarkable-and at times sometimes overwhelming-advancements in the role of artificial intelligence (AI) [. ..].

Open Access PDF

Concepts Keywords
Bioengineering Artificial
Covid Bridging
Healthcare Covid
Pandemic Driven
Tomorrow Health
Healthcare
Intelligence
Pandemic
Possibilities
Public
Sector
Today
Tomorrow
Trends
Unprecedented

Semantics

Type Source Name
drug DRUGBANK Nonoxynol-9
disease MESH COVID-19 pandemic
disease IDO role
disease MESH respiratory diseases
disease IDO contact tracing
disease MESH Delayed treatment
disease IDO intervention
disease MESH emergency
disease IDO blood
disease IDO process
disease MESH glioma
pathway KEGG Glioma
disease MESH brain cancer
disease MESH tumor
disease MESH recurrence
drug DRUGBANK Flunarizine
disease MESH dementia
disease MESH loneliness
disease MESH hemorrhage
drug DRUGBANK Fibrinogen Human
disease MESH hematuria
disease MESH complications
drug DRUGBANK Fosfomycin
disease IDO algorithm
drug DRUGBANK Elm
drug DRUGBANK Spinosad
disease MESH aids
drug DRUGBANK Etoperidone
disease MESH privacy
disease MESH craniosynostosis
disease MESH defects
disease MESH anxiety
disease MESH depression
disease MESH eating disorders
disease MESH heart disease
disease MESH domestic violence
disease IDO quality
disease MESH diagnostic errors
drug DRUGBANK Coenzyme M
disease IDO object
disease MESH Oral Cancer
disease MESH Lung Cancer

Original Article

(Visited 8 times, 1 visits today)